Agomir/antagomir are members of a novel class of chemically engineered oligonucleotides. Agomir is chemically-modified double-strand miRNA mimics which can mimic mature endogenous miRNAs after transfection into cells.

Halozyme Therapeutics, Inc. is a biotechnology company focused on developing and commercializing novel oncology therapies.

Aligos Therapeutics is discovering and developing new classes of compounds that interact directly with disease-causing molecules.